International Incontinence Day 2024: New laser therapies can prevent incontinence after urological or proctological treatment

Minimally invasive laser therapies by biolitec significantly minimize the risk of incontinence in the treatment of prostate and bladder tumors, prostate enlargement, anal fistulas, hemorrhoids and vaginal atrophy. Jena, July 3rd, 2024 – International Incontinence Day took place on June 30th. With around 6 million people affected in Germany alone, incontinence is a widespread condition that is usually kept secret because people are ashamed of it. With the LIFE, FLA, TULA, FiLaC, LHP and LaEvita laser therapies, the medical technology company biolitec offers gentle treatment options in the fields of…

Mehr...
Medicine Wellness Health 

Asahi Kasei launches membrane system to produce water for injection

Leveraging Microza™ expertise to enable lower energy consumption and higher water quality Düsseldorf, Tokyo and New York – June 13, 2024 – Asahi Kasei has announced that in April 2024 it began selling a membrane system to produce WFI (water for injection), a type of sterile water that is used for the preparation of injections. The membrane system was developed as an alternative to the conventional distillation processes for the production of WFI by leveraging system design and development capabilities of Microza™ hollow-fiber membrane for water treatment and filtration of…

Mehr...

Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company

Tokyo, New York, and Düsseldorf – May 28, 2024 – Asahi Kasei Corp. today announces that it will offer the shareholders of Calliditas Therapeutics AB to acquire the shares of the pharmaceutical company Calliditas for the purpose of making Calliditas a wholly-owned subsidiary of Asahi Kasei („the Acquisition“) through a voluntary tender offer for Calliditas („the Tender Offer“). The Tender Offer will also include a concurrent offer by Asahi Kasei to acquire all American Depositary Shares („ADS“), each representing two shares in Calliditas, which will be conducted pursuant to the…

Mehr...
Medicine Wellness Health 

Asahi Kasei Medical completes new assembly plant for Planova™ virus removal filters

Düsseldorf, Tokyo, and New York – May 27, 2024 – Asahi Kasei Medical has completed the construction of its third assembly plant for Planova™ virus removal filters in Nobeoka, Miyazaki, Japan, and held its completion ceremony on May 24, 2024. The bioprocess business of Asahi Kasei Medical comprises Planova™ virus removal filters and equipment used in the manufacturing process of biotherapeutic products such as biopharmaceuticals and plasma derivatives, biosafety testing services, and biopharmaceutical Contract Development and Manufacturing (CDMO) operations. It is one of the Asahi Kasei Group“s businesses to drive…

Mehr...
Medicine Wellness Health 

Leonardo dual diode laser effective for genitourinary syndrome of menopause

Treatment with the Leonardo Dual diode laser from biolitec is an effective and gentle outpatient alternative for genitourinary syndrome of menopause, according to a new study Jena, 14.05.2024 – The LEONARDO Dual diode laser from biolitec has proven itself as an alternative for the treatment of genitourinary syndrome of menopause, according to new study results.1 Due to increasing life expectancy, women today spend a third of their lives after menopause. The hormonal changes that cause the menopause are often associated with considerable symptoms. One of the most common is genitourinary…

Mehr...
Medicine Wellness Health 

Asahi Kasei Bioprocess to Unveil THESYS™ ACS ERGO Synthesis Column at TIDES USA

Düsseldorf, Tokyo and New York – April 30, 2024 – Generating cutting-edge therapeutics requires precision, safety, and efficiency from manufacturing equipment. The next generation of oligo manufacturing, the process of producing short sequences of nucleotides (building blocks of DNA or RNA), innovation from Asahi Kasei Bioprocess (AKB), the THESYS™ ACS ERGO synthesis column, will be on display and demonstrated at Booth 213 at TIDES USA 2024 from May 14th to 17th at the Hynes Convention Center in Boston. This new synthesis column offers drastically reduced changeover time between batches while…

Mehr...
Medicine Wellness Health 

ELVeS laser therapy: For a spring without varicose veins

Spring without varicose veins – All about modern ELVeS laser therapy from biolitec at www.info-krampfader.de/en/ – Expert interviews on minimally invasive laser therapies – Practical reports from doctors – Doctor finder for ELVeS laser procedures Jena, 17.04.2024 – The warm season is just around the corner again. Varicose veins can hardly be concealed with light, spring-like clothing. However, varicose veins are not just about beauty. Because if left untreated, there are health risks. If you suspect you have varicose veins, you should therefore play it safe in good time. With…

Mehr...
Medicine Wellness Health 

Asahi Kasei Bioprocess and Axolabs announce strategic partnership to accelerate oligonucleotide therapeutics development

Düsseldorf, Tokyo and New York – April 11, 2024 – Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics. The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility spanning an area of 59,000 square feet (approximately 5,481 square meters) in Berlin. This cooperation aims to accelerate the development and commercialization of oligonucleotide-based therapies to improve quality of life for patients worldwide. Oligonucleotide therapies offer a targeted approach to modulating gene expression, splicing,…

Mehr...
Medicine Wellness Health 

Asahi Kasei Medical and AW Technologies enter exclusive distribution agreement for TrachFlush in Japan

Düsseldorf and New York – April 3, 2024 – AW Technologies and Asahi Kasei Medical, a core operating company of the Japanese technology company Asahi Kasei, have entered into an exclusive distribution agreement in Japan for AW Technologies“ TrachFlush™ device. AW Technologies is currently in the process of medical device registration of the TrachFlush in Japan, with market launch targeted in fiscal 2024. Developed by AW Technologies based on an invention by an intensivist, the TrachFlush is a medical device to reduce the discomfort of ventilated patients while lightening the…

Mehr...
Medicine Wellness Health 

Asahi Kasei offers pharmaceutical excipient Ceolus™ with nitrite concentration of 0.1 ppm or less

Tokyo, New York, and Düsseldorf – February 27, 2024 – To contribute to reducing the risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals and nutritional supplements, Asahi Kasei now offers Ceolus™ microcrystalline cellulose (MCC) with nitrite levels of 0.1 μg/g (ppm) or less. In 2018, a potentially carcinogenic nitrosamine impurity was detected in several pharmaceuticals. Since then, public awareness of the potential health hazards of nitrosamine has increased significantly worldwide. Guided by regional authorities such as the European Medicines Agency (EMA) and the U.S. Food & Drug Administration (FDA), the…

Mehr...